Publication | Open Access
Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus
227
Citations
35
References
1991
Year
Primary ImmunodeficiencyProgressive Immune DysfunctionVeterinary VaccineFeline Immunodeficiency VirusLaboratory ImmunologyVirus InfectionVeterinary PathologyImmunologyVeterinary SciencePetaluma IsolateVirologyAntiviral ResponseAutoimmunityChronic Viral InfectionHivMedicineViral ImmunityAnimal Virus
Within 6 months of infection with the Petaluma isolate of feline immunodeficiency virus, specific-pathogen-free domestic cats exhibited a decrease in the percentage and number of circulating CD4+ lymphocytes and in the CD4+/CD8+ T-cell ratio, along with a marginally significant depression of pokeweed mitogen-induced lymphocyte proliferation in vitro. There was no loss of responsiveness to concanavalin A during this stage, and the cats were capable of mounting a satisfactory antibody response to a T-dependent, synthetic polypeptide immunogen. The pokeweed mitogen response deficit became clearly demonstrable by 11 to 12 months postinfection. A decline in the lymphocyte proliferative response to concanavalin A and a diminished ability to mount an in vivo antibody response to the T-dependent immunogen evolved by 25 to 44 months postinfection. Virus infection did not affect the ability of cats to mount an antibody response to a T-independent synthetic polypeptide immunogen. These data indicate that feline immunodeficiency virus produces a slowly progressive deterioration of T-cell function but does not affect the ability of B cells to recognize and respond to a T-independent antigenic stimulus.
| Year | Citations | |
|---|---|---|
Page 1
Page 1